Open Access Open Access  Restricted Access Subscription or Fee Access

Applications of Recombinant DNA Technology in Medicine

Rahul Sharma


Recombinant DNA technology is the method of genetic engineering in which recombinant DNA is prepared by cutting the DNA into small fragments and joining different fragments together taken from different organisms. This Procedure makes it possible to take any gene from any specie and place this gene in any other organism or species. It is similar to cloning because when the foreign gene is inserted in an organism like bacteria then, multiple copies are made through cloning to use the gene in different applications. This article throws light upon the top five applications of recombinant DNA technology in medicine.

Full Text:



M. Venter. Synthetic promoters: genetic control through cis engineering, Trends Plant Sci. 2007; 12(3): 118–24p.

A. Berk, S.L. Zipursky. Molecular Cell Biology. Vol. 4, New York, NY: WH Freeman; 2000.

M. Bazan-Peregrino, R.C.A. Sainson, R.C. Carlisle, et al. Combining virotherapy and angiotherapy for the treatment of breast cancer, Cancer Gene Ther. 2013; 20(8): 461–8p.

L.-X. Li, Y.-L. Zhang, L. Zhou, et al. Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells, J Transl Med. 2013; 11(1): article 257.

C. Méndez, J.A. Salas. On the generation of novel anticancer drugs by recombinant DNA technology: the use of combinatorial biosynthesis to produce novel drugs, Combin Chem – High Through Screen. 2003; 6(6): 513–26p.

B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, D.T. Baird. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency, Hum Reprod Update. 2009; 15(3): 309–21p.

O. Merten, B. Gaillet. Viral vectors for gene therapy and gene modification approaches, Biochem Eng J. 2016; 108: 98–115p

O.-W. Merten, M. Schweizer, P. Chahal, A.A. Kamen. Manufacturing of viral vectors for gene therapy: part I. Upstream processing, Pharm Bioprocess. 2014; 2(2): 183–203p.

S.L. Ginn, I.E. Alexander, M.L. Edelstein, M.R. Abedi, J. Wixon. Gene therapy clinical trials worldwide to 2012 – an update, J Gene Med. 2013; 15(2): 65–77p.

A. Rivero-Müller, S. Lajić, I. Huhtaniemi. Assisted large fragment insertion by Red/ET-recombination (ALFIRE) – an alternative and enhanced method for large fragment recombineering, Nucleic Acids Res. 2007; 35(10): article e78.



  • There are currently no refbacks.